Approaches to Alleviating Costs for Patients and Payers
The cost of oncology products can be ameliorated, to some extent, for payers and patients, by using imaginative reimbursement approaches. Some may involve risk shares. Some may involve other managed entry schemes that pay by outcomes. Those can help with the burden of cost for patients and payers.